Skip to content
10-Q

Quarterly Report

Telesis Bio Inc.

0000950170-24-093244

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 31, 2024 1.77M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.73M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.7M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.65M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.65M sh
Capex Q2 2024 · Jun 30, 2024 $583K
Capex restated Q2 2024 · Jun 30, 2023 $1.55M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$8.58M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$21.47M
Long Term Debt Q2 2024 · Jun 30, 2024 $5.28M
Long Term Debt Q2 2024 · Dec 31, 2023 $5.27M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $6.4M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $1.57M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$20.54M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$8.24M
Stockholders Equity Q2 2024 · Dec 31, 2023 $238K
Stockholders Equity Q2 2024 · Jun 30, 2023 $27.92M
Stockholders Equity Q2 2024 · Mar 31, 2023 $36.62M
Stockholders Equity Q2 2024 · Dec 31, 2022 $46.57M
Current Liabilities Q2 2024 · Jun 30, 2024 $8.01M
Current Liabilities Q2 2024 · Dec 31, 2023 $8.18M
Total Liabilities Q2 2024 · Jun 30, 2024 $42.78M
Total Liabilities Q2 2024 · Dec 31, 2023 $40.87M
Current Assets Q2 2024 · Jun 30, 2024 $15.16M
Current Assets Q2 2024 · Dec 31, 2023 $30.35M
Total Assets Q2 2024 · Jun 30, 2024 $52.73M
Total Assets Q2 2024 · Dec 31, 2023 $70.41M
Eps Diluted Q2 2024 · Jun 30, 2024 −$7.62
Eps Diluted Q2 2024 · Jun 30, 2024 −$13.17
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$5.10
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$11.85
Eps Basic Q2 2024 · Jun 30, 2024 −$7.62
Eps Basic Q2 2024 · Jun 30, 2024 −$13.17
Eps Basic restated Q2 2024 · Jun 30, 2023 −$5.10
Eps Basic restated Q2 2024 · Jun 30, 2023 −$11.85
Sga Expense Q2 2024 · Jun 30, 2024 $5.51M
Sga Expense Q2 2024 · Jun 30, 2024 $10.48M
Sga Expense restated Q2 2024 · Jun 30, 2023 $5.29M
Sga Expense restated Q2 2024 · Jun 30, 2023 $10.4M
Rd Expense Q2 2024 · Jun 30, 2024 $2.47M
Rd Expense Q2 2024 · Jun 30, 2024 $4.83M
Rd Expense restated Q2 2024 · Jun 30, 2023 $3.92M
Rd Expense restated Q2 2024 · Jun 30, 2023 $8.41M
Net Income Q2 2024 · Jun 30, 2024 −$12.59M
Net Income Q2 2024 · Jun 30, 2024 −$21.22M
Net Income Q2 2024 · Mar 31, 2024 −$8.64M
Net Income Q2 2024 · Jun 30, 2023 −$8.29M
Net Income Q2 2024 · Jun 30, 2023 −$19.41M
Net Income Q2 2024 · Mar 31, 2023 −$11.12M
Operating Income Q2 2024 · Jun 30, 2024 −$11.49M
Operating Income Q2 2024 · Jun 30, 2024 −$19.28M
Operating Income restated Q2 2024 · Jun 30, 2023 −$7.44M
Operating Income restated Q2 2024 · Jun 30, 2023 −$17.93M
Gross Profit Q2 2024 · Jun 30, 2024 −$799K
Gross Profit Q2 2024 · Jun 30, 2024 $308K
Gross Profit restated Q2 2024 · Jun 30, 2023 $4.97M
Gross Profit restated Q2 2024 · Jun 30, 2023 $7.75M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $2.35M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $3.43M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $2.04M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $3.93M
Revenue Q2 2024 · Jun 30, 2024 $1.55M
Revenue Q2 2024 · Jun 30, 2024 $3.74M
Revenue restated Q2 2024 · Jun 30, 2023 $7M
Revenue restated Q2 2024 · Jun 30, 2023 $11.68M